These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28964482)

  • 21. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL; Marcus R; Bradley JA
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.
    Mynarek M; Schober T; Behrends U; Maecker-Kolhoff B
    Clin Dev Immunol; 2013; 2013():814973. PubMed ID: 24174972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
    Shpilberg O; Wilson J; Whiteside TL; Herberman RB
    Leuk Lymphoma; 1999 Dec; 36(1-2):109-21. PubMed ID: 10613455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing the challenge of PTLD in liver and bowel transplant recipients.
    Lauro A; Arpinati M; Pinna AD
    Br J Haematol; 2015 Apr; 169(2):157-72. PubMed ID: 25377273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-transplant lymphoproliferative disorders.
    Singavi AK; Harrington AM; Fenske TS
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients.
    Wistinghausen B; Gross TG; Bollard C
    Pediatr Hematol Oncol; 2013 Sep; 30(6):520-31. PubMed ID: 23802715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
    Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
    Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prompt diagnosis and management of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and hemophagocytosis: A dreaded complication in a post-liver transplant child.
    Jha B; Mohan N; Gajendra S; Sachdev R; Goel S; Sahni T; Raina V; Soin A
    Pediatr Transplant; 2015 Nov; 19(7):E177-80. PubMed ID: 26184957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH; Morrison VA
    Expert Rev Hematol; 2010 Feb; 3(1):35-44. PubMed ID: 21082932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.
    Preiksaitis JK; Keay S
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S38-46. PubMed ID: 11389521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
    Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transplant lymphoproliferative disorder: a review.
    Loren AW; Porter DL; Stadtmauer EA; Tsai DE
    Bone Marrow Transplant; 2003 Feb; 31(3):145-55. PubMed ID: 12621474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.